California Cancer Reporting System Standards, Volume III
|
CCR ID |
NAACCR ID |
|
E1463 |
2073 |
Site/Laterality/EOD conflict. This over-ride is used with SEER IF41.
Edits of the type Site, Laterality, EOD apply to paired organs and identifies EOD specified as in situ, localized or regional by direct extension if laterality is coded as "bilateral, site unknown," or "laterality unknown."
Admission, Tumor
1
|
1 |
Reviewed (and both site and histology are correct |
|
Blank |
Not reviewed or reviewed and corrected |
Before CP26, Eureka defined 0 as not reviewed.
Load each individual override flag value as a separate element value.
Tumor Level
New Case Consolidation
If the admission’s over-ride flag is 1 and the tumor’s over-ride flag is blank, then automatically update the tumor’s over-ride flag with the admission’s corresponding over-ride flag
Manual Change
Admission Level
Manual Change or Correction Applied
Yes
IF432 Primary Site, Laterality, EOD--Extension, Histol ICDO3, OR Site Lat EOD
| 7/01 | Changed HIST-TYPE references to HIST-TYPE-3 references. |
| 3/04 | Updated table format and corrected level information. |
| 10/07 | Override flags separated out on individual pages. Converted database so CCR allowable values match NAACCR standards (CCR value for not reviewed = blank, NAACCR value for not reviewed=0). |
| 11/08 | Added IF 798 to prevent Over-ride flag misuse. |
| 2010 | Data Item: CCR name (OR Site Lat EOD) changed to NAACCR name. Rewrote Update logic. |